BriaCell Therapeutics(BCTX)
$3.06-0.10 (-3.16%)
BCTX
BriaCell Therapeutics financials statements
$3.06
At close:-0.10 (-3.16%)
BriaCell Therapeutics (BCTX) Income Statement
336 Followers
BriaCell Therapeutics Income Statement
Last quarter (Q4 2026), BriaCell Therapeutics's total revenue was C$0.00. In Q4, BriaCell Therapeutics's net income was C$-12.13M. See BriaCell Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jul 26 | Jul 25 | Jul 24 | Jul 23 | Jul 22 |
|---|---|---|---|---|---|
| C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | |
| C$ -121.09K | C$ -107.93K | C$ 0.00 | C$ 0.00 | C$ 0.00 | |
| C$ 36.46M | C$ 27.43M | C$ 33.33M | C$ 23.27M | C$ 15.29M | |
| Depreciation and Amortization | C$ 121.09K | C$ 107.93K | C$ 83.90K | C$ 15.27K | C$ 15.27K |
| C$ -36.46M | C$ -27.43M | C$ -4.85M | C$ -23.26M | C$ -26.82M | |
| C$ -36.58M | C$ -27.54M | C$ -33.33M | C$ -23.27M | C$ -15.29M | |
| C$ 739.66K | C$ 656.60K | C$ 28.40M | C$ 2.97M | C$ -11.55M | |
| C$ -35.84M | C$ -26.88M | C$ -4.93M | C$ -20.30M | C$ -26.84M | |
| C$ -35.42M | C$ -26.63M | C$ -4.79M | C$ -20.30M | C$ -26.84M | |
| Per Share Metrics | |||||
| Basic EPS | C$ -7.07 | C$ -62.95 | C$ -43.68 | C$ -195.00 | C$ -259.50 |
| Diluted EPS | C$ -7.07 | C$ -62.95 | C$ -43.68 | C$ -195.00 | C$ -259.50 |
| Weighted Average Shares Outstanding | 5.01M | 423.11K | 109.70K | 104.13K | 103.29K |
| Weighted Average Shares Outstanding (Diluted) | 5.01M | 423.11K | 109.70K | 104.13K | 103.29K |
Currency in CAD
